US2013267009A1PendingUtilityA1

Rationally-Designed Single-Chain Meganucleases With Non-Palindromic Recognition Sequences

Assignee: PREC BIOSCIENCES INCPriority: Oct 31, 2007Filed: May 20, 2013Published: Oct 10, 2013
Est. expiryOct 31, 2027(~1.3 yrs left)· nominal 20-yr term from priority
A61P 31/00A61P 31/12A61P 31/04A61P 33/02A61P 43/00C12N 9/16C12Y 301/00C12N 2800/80C12N 9/22C12Y 301/04C12N 15/907C12N 15/902C12N 15/8509
65
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Disclosed are rationally-designed, non-naturally-occurring meganucleases in which a pair of enzyme subunits having specificity for different recognition sequence half-sites are joined into a single polypeptide to form a functional heterodimer with a non-palindromic recognition sequence. The invention also relates to methods of producing such meganucleases, and methods of producing recombinant nucleic acids and organisms using such meganucleases.

Claims

exact text as granted — not AI-modified
1 . A recombinant single-chain meganuclease comprising:
 (a) a first subunit comprising a polypeptide having at least 85% sequence identity to residues 9-151 of SEQ ID NO: 1;   (b) a second subunit comprising a polypeptide having at least 85% sequence identity to residues 9-151 of SEQ ID NO: 1; and   (c) a polypeptide linker comprising 28-43 amino acids, said polypeptide linker being covalently bound to said first and said second subunit;   said first subunit being covalently bound to said polypeptide linker at a residue corresponding to a position selected from the group of positions 153-163 of SEQ ID NO: 1;   said second subunit being covalently bound to said polypeptide linker at a residue corresponding to a position selected from the group of positions 1-9 of SEQ ID NO: 1;   wherein said first and second subunits are capable of functioning together to recognize and cleave a non-palindromic DNA sequence.   
     
     
         2 . The recombinant single-chain meganuclease of claim  38 , wherein said polypeptide linker comprises at least 50% of polar uncharged amino acids.

Join the waitlist — get patent alerts

Track US2013267009A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.